Diagnosis and management of the HCV/HIV-coinfected patient.
Sherman
Kenneth E
KE
Hepatology and Liver Transplantation Section, University of Cincinnati College of Medicine, Ohio, USA.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D012254:Ribavirin / Q000009:adverse effects / Q000627:therapeutic use
D019380:Anti-HIV Agents; D016898:Interferon-alpha; D012254:Ribavirin